跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,721 条关于
“AXS-17”
全部
23,721
临床试验
17,667
药物
818
机构
223
资讯
5,013
10个月前
Axsome Therapeutics Acquires Novel GABA-A Receptor Modulator AZD7325 for Epilepsy Treatment
10个月前
Fortress Biotech Reports Strong Q3 2025 Results with Strategic Asset Sales and Pipeline Advances
去年
Axsome's AXS-05 Shows Promise in Alzheimer's Agitation Trials, NDA Submission Planned for 2025
8个月前
Axsome Therapeutics Receives FDA Priority Review for AXS-05 in Alzheimer's Disease Agitation
去年
Novel NMDA Inhibitor AXS-05 Shows Promise for Alzheimer's Agitation Without Antipsychotic Risks
去年
Axsome Submits FDA Application for AXS-05 in Alzheimer's Disease Agitation Following Positive Phase 3 Results
去年
AXS-12 Demonstrates Long-Term Efficacy and Safety in Narcolepsy Phase 3 Trial
2年前
FDA Accepts Axsome's NDA Resubmission for AXS-07 in Acute Migraine Treatment
去年
Osteogenon Accelerates Bone Union and Reduces Complications in Lower Leg Fractures
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
第 1 页,共 502 页
上一页
下一页